Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation
Although rare, atopic dermatitis can occur after HSCT, and dupilumab may be safe and effective for refractory conditions.
Authors
- Hyun Jung Jin (ORCID: https://orcid.org/0000-0003-2888-420X)
- Young‐Hee Nam (ORCID: https://orcid.org/0000-0001-8759-2982)
Institutions
- Dong-A University (KR)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1186/s13223-025-00966-3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dong-A University